Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 26006 clinical trials
DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation

We will also validate whether DWIBS-MRI ADC values can be used to accurately differentiate benign from malignant lesions. Additionally, because it is not known whether tumor type or growth rate (Ki67 values) will affect our results, we will include these parameters in our analysis. Once we validate the use of …

mammogram
breast imaging reporting and data system
ki-67
  • 0 views
  • 19 Feb, 2024
  • 1 location
Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study

The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cells) and the genes within the tumour. These characteristics may be useful in choosing treatments for patients for …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

In this study, patients with advanced solid tumors will undergo [18F]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

This system is designed to examine tissue removed during breast cancer surgery to see whether the tissue's edges contain cancer. The current standard of practice is to remove the breast tumor tissue and send the tissue to the lab for analysis following surgery.

cancer
breast cancer
lumpectomy
invasive breast cancer
breast tumor
  • 0 views
  • 19 Feb, 2024
  • 1 location
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test

This study prospectively included 150 breast cancer patients (30 patients in the first stage and 120 patients in the second stage) who were treated with the commonly used neoadjuvant chemotherapy recommended by NCCN, received surgical treatment after neoadjuvant chemotherapy, and evaluated the efficacy according to the surgical pathological response.Based on …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Giessen Pulmonary Hypertension in Lung Cancer Registry

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Off-label Use of Anti-cancer Drugs in Norway -a Prospective Cohort Study

Further, the study will give a descriptive analysis of the current practice of off-label use of anti-cancer drugs in Norway, including prevalence estimation and health care related cost analyses.

cancer
off label use
antineoplastic agents
cancer diagnosis
  • 0 views
  • 19 Feb, 2024
  • 1 location
BIOPSY SCANNER LLTECH Technology for Diagnosis of Breast Cancer

Breast cancer is a frequent pathology and the speed of initial diagnosis makes it possible to improve the course of care and to reduce the anxiety of the patients.

immunohistochemistry
breast imaging reporting and data system
biopsy of breast
  • 0 views
  • 19 Feb, 2024
  • 1 location
Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy

Neoadjuvant systemic therapy (NST) is increasingly recommended for patients with early breast cancer, and the rate of patients with pathological complete remission (pCR) is increasing due to the use of modern chemotherapy regimens and targeted therapies, especially in patients with human epidermal growth factor receptor 2 positive (HER2+) breast cancer …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Communication Training for Cancer Patients Their Caregivers and Their Doctors

The long-term goals of developing and testing VOICE 2.0 include improving the care and respecting the wishes of cancer patients, and helping those patients and their caregivers have an improved quality of life during their experience with cancer.

  • 0 views
  • 19 Feb, 2024
  • 1 location